Privia Health Group (PRVA) vs Schrodinger (SDGR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Schrodinger (SDGR) has outperformed Privia Health Group (PRVA) over the past year, gaining 35.4% versus a loss of 15.5%. Over five years, PRVA leads with a -13.7% price change compared with -50.7% for SDGR. Privia Health Group is the larger company by market cap ($2.59 billion vs $2.04 billion), about 1.3 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | PRVA | SDGR |
|---|---|---|
| Share price | $20.30 | $27.29 |
| Market cap | $2.59B | $2.04B |
| 1-day change | +0.10% | -5.57% |
| YTD return | -14.38% | +52.63% |
| 1-year return | -15.45% | +35.37% |
| 5-year return | -13.65% | -50.70% |
| P/E ratio (TTM) | 96.67 | — |
| Forward P/E | 19.13 | — |
| EPS (TTM) | $0.21 | $-0.74 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $28.82 | $33.78 |
| 52-week low | $18.92 | $10.95 |
| Distance from 52-week high | -29.56% | -19.21% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +55.02% | -21.47% |
| Average volume | 1.23M | 1.69M |
| Shares outstanding | 127.73M | 65.64M |
| Employees | 1,226 | 850 |
| Sector | Health Care | Health Care |
| Industry | Medical/Nursing Services | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- SDGR has outperformed PRVA by 50.8 percentage points over the past year.
About Privia Health Group
PRVA stock →Privia Health Group, Inc. operates as a national physician-enablement company in the United States.
Health Care · Medical/Nursing Services · 1,226 employees
About Schrodinger
SDGR stock →Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middle East, Africa, and internationally. The company operates in two segments, Software and Drug Discovery.
Health Care · Biotechnology: Pharmaceutical Preparations · 850 employees
PRVA vs SDGR FAQ
Which is bigger, Privia Health Group or Schrodinger?
Privia Health Group (PRVA) is larger, with a market capitalization of $2.59B compared with $2.04B for Schrodinger (SDGR).
Which stock has performed better over the past year, PRVA or SDGR?
SDGR returned +35.37% over the past 12 months, compared with -15.45% for PRVA (price return, excluding dividends). Past performance does not predict future results.
Are Privia Health Group and Schrodinger in the same industry?
Both are in the Health Care sector, but in different industries: Medical/Nursing Services for Privia Health Group and Biotechnology: Pharmaceutical Preparations for Schrodinger.